Australian Cavalier Health

The ” NEBL3 or AG” gene in Cavalier King Charles Spaniels serves as a genetic marker within the NEBL gene, offering  possible protection against early-onset Myxomatous Mitral Valve Disease (MMVD), a leading cause of death in the breed. Understanding this genetic variation can assist breeders in making informed decisions and help owners manage their pet’s health effectively.

Why is this important for the Cavalier breed? 

Its early days and we wont really know for about 10 years the full impact on our lovely breed,  BUT, it is looking very positive, This gene may help prevent the heart from enlarging due,  NEBL3 does not work directly on the mitral valve but influences the integrity of the papillary muscle, which supports the valve.

How NEBL3 works:

• Gene Expression:The NEBL3 gene provides instructions for making a protein called nebulette. Structural Support:The nebulette protein is important for the integrity of the papillary muscle, a crucial structure that supports the heart’s mitral valve. Preventing Cardiac Enlargement:In individuals with the wild-type NEBL3 variant, the nebulette protein maintains the papillary muscle’s health, preventing the heart from dilating in response to valve insufficiency, which is a key aspect of MMVD. MMVD Progression: When the papillary muscle degenerates, the valve leaflets are pulled apart, increasing the leak and worsening the condition. The NEBL3 variant helps to slow this process. 

NEBL3 and MMVD in Dogs:

Genetic Testing: Genetic tests for the NEBL3 variant can identify dogs at lower risk for MMVD. 

Breed-Specific: This research has primarily focused on CKCS and Dachshunds. 

Breeding Strategy: Understanding the NEBL3 gene allows breeders to make informed decisions to potentially reduce the prevalence of early-onset MMVD in these breeds. 

Key Takeaways:

• NEBL3 plays a role in maintaining the health of the heart’s support structures, not the valve itself. 
• The wild-type NEBL3 variant is protective against early MMVD and helps to slow its progression. 
• Genetic testing for NEBL3 can be a valuable tool for breeders in creating healthier Cavalier King Charles Spaniels and Dachshunds

The AG gene

In Cavalier King Charles Spaniels (CKCS) in Australia, the “AG” gene refers to a genetic marker in the NEBL gene that provides protection against developing early-onset Myxomatous Mitral Valve Disease (MMVD). Dogs with an AG or GG genotype are less likely to be diagnosed with MMVD early in life, while dogs with an AA genotype are more likely to be affected by the condition, which is a leading cause of death in the breed.    An AI overview of the NEBL3 or the AG gene

What is the AG Gene Marker?

• The AG gene marker is found within the NEBL gene.
• It’s a protective genetic variant that influences a dog’s likelihood of developing MMVD.
• A dog’s genotype can be either AA, AG, or GG. 

Genotype Implications

• AG or GG:These dogs are considered to have a protective genetic makeup against MMVD, meaning they are less likely to be diagnosed with the disease at a young age. 
• AA:These dogs are more likely to develop MMVD early in life and require more careful monitoring. 

Why is this important for Cavalier Owners and Breeders?

• Breeders can use this DNA test to screen their adult dogs and make informed breeding decisions.
• For pet owners, understanding the genetic status of their Cavalier can help with early veterinary care and monitoring.